Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bromide Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN104418779A details a scalable Fudosteine process. Achieves 99.5% purity with reduced steps and environmental impact for global supply chains.
Patent CN111675650A details a green photo-induced synthesis for aromatic vinyl bromides. Delivers cost reduction in pharmaceutical intermediate manufacturing with high purity.
Patent CN102675049B details a ZnBr2-promoted synthesis of optically active axially chiral alpha-allenols. Offers high ee values and scalable routes for pharma intermediates.
Novel catalytic process for Apixaban intermediates reduces production costs and improves yield significantly for pharmaceutical manufacturing supply chains globally seeking reliable partners.
Discover how advanced cuprous bromide activation and palladium-catalyzed hydrogenation reduce solid waste by 90% while achieving 99.8% purity and 72% yield for AZD9291 production.
Discover how water-based bromide/persulfate synthesis of 3-hydroxyisoindol-1-one reduces metal residues, eliminates organic solvents, and cuts production costs for pharmaceutical intermediates.